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    Human serum albumin (HSA) is the most abundant protein  constituent of blood plasma.  This protein 
consists of a single polypeptide chain of 585 amino acid residues, which has many important physiological 
functions. HSA can bind and carry many drugs, including anticoagulants, tranquilizers, and general  
Anesthetics. Some technique such as: fluorescence spectroscopy, three-dimensional fluorescence, UV–
visible, FT-IR, circular dichroism (CD), X-ray scattering (SAXS) technique and molecular modeling was 
utilized to investigate the effects of acceptor on conformation of the donor (HSA). The binding site number 
n and apparent binding constant KA drugs corresponding thermodynamic parameters, the free energy change 
(∆G), enthalpy change (∆H), and entropy change (∆S) were calculated. The hydrophobic effect, van der 
Waals forces, hydrogen bond and electrostatic interactions play a major role in stabilizing the complex. 
More investigation also revealed that these drugs bind to the amino acids on the hydrophobic pocket of HSA 
and induce changes to the secondary structure of the HSA. In this study for better understanding of HSA-
drug interactions, we categorized drugs into ten groups from years 2006 to 2012 and are suggested that two 
important parameters such as ΔG
0
H20 and [D] 1/2 can be calculated for each groups and refer to ten categories 
to finally indicate that fine structural change in human serum albumin. 
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INTRODUCTION  
     Investigating drugs-plasma proteins 
interactions is an interesting research field in 
biochemistry and clinical medicine. Human 
Serum Albumin (HSA), an important globular 
protein, is considered as carrier, responsible for 
blood osmotic pressure and several other 
important functions and also has three high 
affinity specific binding sites (I, II and III) for 
drugs. X-ray crystallography analyses have 
revealed that the drug binding sites are located in 
sub domains IIA and IIIA [1,2]. The three-
dimensional structure of human serum albumin 
has been determined through X-ray 
crystallography measurements [3]. This globular 
protein has three domains that including two sub 
domains (A and B) which are stabilized by 17 
disulfide bridges [4]. The drug-protein binding 
affinity is an important factor for regulation of 
drug concentration in blood. So, this binding 
property can change the activity and half life of 
the drug in the body [5]. HSA involves in 
distribution, transportation and metabolism of a 
wide variety of ligands including different 
metabolites and pharmaceutical reagents and also 
maintenance of the blood osmotic pressure [6]. 
Due to its importance and characteristics, 
researchers usually use HSA as a protein model 
for study the complexes of proteins and drugs [7]. 
HSA binds to many poorly water soluble drugs 
and carry them through the blood stream [8, 9]. 
Following this binding, metabolism distribution, 
free concentration and elimination rate of various 
drugs can be significantly regulated [10].various 
techniques are used for investigating plasma 
protein-drug interaction including fluorescence, 
 




pH-metery, circular dichorism (CD) and 
calorimetery techniques[3]. In this review, HSA-
drug interaction is investigated and classified 
articles published from years 2006 to 2012. Ten 
Categories of drugs that can bind and transport by 
HSA are as follows: Anti-Tumor, Antibiotics, 
Antivirus, Non-Steroid, Pain killer, Antifungal, 
Nerve agent, Chinese medicine, Anti-insect and 
the group of Others. Here their interactions are 
discussed in detail and finally give an insight on 
HSA ability for drug management in body is 
represented. 
 1) Anti-Tumor 
   Anti tumors are among the most important 
drugs, so many investigations carried out on 
binding properties of this group of drugs. 
Nucleosides and their derivatives exhibit 
significant antitumor, antiviral, and antibacterial 
activities. Nobiletin is regarding as a promising 
anti-inflammatory and anti-tumor promoting 
agent. Using fluorescence, UV–vis, FT-IR, CD 
techniques and molecular modeling, the binding 
of Nobiletin to HSA was studied. It is shown that 
the CD and FT-IR spectra were changed after its 
binding to the ligand. According to some 
Computational mapping, it is suggested that 
Nobiletin is binding to the large hydrophobic 
cavity of subdomain IIA [4]. Due to the presence 
and importance of metal ions in plasma, the 
impact of Cu
2+
 on the interaction of 
Anthracenedione mitoxantrone as an antitumor 
agent and HSA is investigated using fluorescence 
spectroscopy, ultraviolet–visible absorption 
spectroscopy and circular dichroism 
spectroscopy. It is reported that the presence of 
Cu
2+
 significantly increases the quenching 
efficiency of MTO to HSA. Cu2+ also induces 
changes on the secondary structure of HSA with 
an increase in the α-helix content [7]. In another 
study, researchers investigated the binding of 30-
azido-30-deamino daunorubicin (ADNR) to 
HSA at different temperatures and pH 7.4. 
Fluorescence spectroscopy showed that the 
hydrophobic forces play an important role in the 
interaction between ADNR and HSA [11].In 
addition; the effects of common  ions on the 
binding constants were also studied at room 
temperature [11, 12]. 
Hydrogen bond has been shown to be the major 
intermolecular force in stabilizing the docetaxel–
HSA complex. CD, FT-IR and UV–visible 
spectroscopy supported the occurrence of 
changes in the secondary structure of HSA 
following the interaction between docetaxel (an 
anti neoplastic agent of the taxoid family) and 
HSA [13].By the combination of fluorescence 
spectroscopy, UV absorption and molecular 
modeling it is revealed that the hydrophobic 
interaction was the predominant intermolecular 
force stabilizing the complex of HSA and 
daunorubicin (an anticancer drug) by calculating 
the Vant’Hoff equation [11]. Paclitaxel (Taxol, a 
potent anticancer drug) is shown to interact with 
HSA at the binding sites located at the interface 
of subdomains IIA and IIIA, and in the cleft 
between either domains of I and III of the 
protein, respectively. It is also claimed that the 
binding mode is regulated by the C13 side chain 
[14]. 
The interaction of JDC-108 (1, 11-Didechloro-6-
methyl-40-O-demethyl rebeccamycin) and HSA 
is also showed that hydrophobic forces are very 
important in the reaction and the binding 
reaction is mainly entropy-driven [15]. It is 
reported that following the interaction of 
fluoxymesterone  (FLU) and cyclophosphamide 
(CYC) with HSA, α-helix content of HSA 
decreased as drug concentration increased. Both 
drugs also cause some conformational changes 
in HSA [16]. Based on the quantitative 
information provided by calorimetric and 
spectroscopic techniques, It is reported that the 
binding of mitoxantrone with HSA is dominated 
by electrostatic interactions [17]. 
 2) Antibiotics 
   Antibiotics are widely used in treatment of 
different infectious and daily life [18]; so many 
researches are done to study the features of 
antibiotics interactions with HSA. Xin-Xiang 
Zhang et al. reported that hydrogen bonds and 
van der Waals interactions are dominated in the 
binding of fluoroquinolones to HSA [19]. 
Mechanism of interaction and detailed physico-
chemical characterization of the binding of four 
fluoroquinolones:levofloxacin, sparfloxacin, 
ciprofloxacin HCl and enrofloxacin with human 
serum albumin has been studied. It is shown that 
under the physiological pH, levofloxacin, 
ciprofloxacin, hydrochloride, enrofloxacin and 
sparfloxacin interaction with HSA is dominated 
 




by hydrogen bonding, Van der Waal’s 
interactions, hydrophobic interactions, hydrogen 
bonding, and hydrophobic and electrostatic 
interactions respectively. No changes in the 
secondary structure of HSA are seen following 
the presence of these drugs as it reported by the 
authors [20].The same as sparfloxacin , 
hydrophobic and electrostatic interactions play 
an important role in interaction of 
chloramphenicol with HSA as it studied by 
UV/vis, circular dichroism (CD) and three-
dimensional fluorescence [21]. The interaction 
between HSA and sulfamethazine (SMZ) is also 
mainly occurring via Electrostatic interaction 
and hydrogen bond .This binding can unfold the 
polypeptides of HSA and transfer the HSA 
secondary conformation [18]. Interactions of 
paeonol with human serum albumin (HSA) have 
been investigated  by calorimetry and circular 
dichroism. Paeonol has been used as a 
tranquillizer and anti-bacterial properties . The 
binding constant, changes of enthalpy, entropy, 
and Gibbs free energy were  obtained. Circular 
dichroism (CD) spectra showed that paeonol 
changes the secondary structure of HSA [22]. 
Flavonoid drugs are often have high affinity for 
binding to the HSA. The previous reports on 
these  [8–11] involve quercetin, kaempferol, 
delphinidin, scutellarin,  alpinetin, formononetin 
and Farrerol have been shown a spectrum of 
physiological activities such as anti-bacterial and 
the conformational changes of HSA was 
observed caused by the interaction with farrerol 
[23]. 
 3) Antivirus 
    In category of anti viral drugs, researches have 
shown that the HSA is partially unfolded in the 
complex of HSA- Betulinic acid (BA, effective 
against cancerous and HIV-infected cells). BA 
can bind to free HSA at nano molar 
concentrations [24].  
HSA is shown to be stabilized at low 
concentrations of the Oseltamivir phosphate 
(OP;tamiflu), an antiviral pro-drug, while at the 
high concentrations of the drug, a partial 
destabilization is observed in drug-HSA 
complex[25]. UV–Vis and fluorescence 
quenching methods in combination with Fourier 
transformed infrared (FT-IR) and circular 
dichroism (CD) spectroscopy revealed that 
silibinin, a naturally occurring compound  for 
treating a range of hepatitic diseases, interacts 
HSA and form a complex mainly via 
electrostatic interactions, it also induces some 
changes to the secondary structure of  HSA [26]. 
4) Non-Steroid 
In this class of drugs, it is reported that the 
complex of HSA-rofecoxib is mainly stabilizing 
by van der Waals interaction and hydrogen 
bonds under physiological condition. Rofecoxib 
is a non-steroidal  anti-inflammatory drug. More 
investigation also revealed that this drug binds to 
the amino acids  on the hydrophobic pocket of 
HSA and induce changes to the secondary 
structure of the H 
SA [27]. The interaction between indomethacin 
and human serum albumin (HSA) was 
investigated by fluorescence quenching 
technique and UV–vis absorption spectroscopy. 
Indomethacin is a member of the arylalkanoic 
acid class of non-steroidal anti-inflammatory 
drugs (NSAIDs), The distance r between donor 
(HSA) and acceptor (indomethacin) was 
obtained according to fluorescence resonance 
energy transfer (FRET).  
The study suggests that the donor and the 
acceptor are bound at different locations but 
within the quenching distance [28]. Meloxicam 
is a non-steroidal anti-inflammatory drug. The 
interaction of meloxicam with HSA in aqueous 
solution and at physiological pH is shown to 
greatly decrease the affinity of albumin for 
bilirubin (40% reduction in the CD Cotton effect 
intensity and 15% reduction of the fluorescence 
intensity) [29]. The binding of ketoprofen with 
human serum albumin (HSA) was studied by 
fluorescence and absorption spectroscopic 
methods. Ketoprofen is a non-steroidal anti-
inflammatory drug. The thermodynamic 
parameters, ∆H, ∆G and ∆S were calculated and 
the main sort of acting force between ketoprofen 
and HSA was studied [30]. 
5) Antifungal 
    Thiophanate methyl (MT), as widely used 
fungicides, is claimed to bind to the HSA mainly 
through hydrophobic forces and also formation 
of hydrogen bonds between the pesticides and 
the residues of HSA [31]. Another fungicide, 
methyl thiophanate (MT), is reported to bind to 
HSA primarily at sub-domain IIA [32]. 
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6) Nerve agent 
    Fluoxetine hydrochloride (FLX), a well known 
psychotropic drug, is mainly bind to the site I of 
HSA and induces some conformational changes 
to HSA after interaction [33]. clozapine as a drug 
used for treatment of schizophrenia, binds to the 
subdomain IIA human serum albumin, through 
hydrophobic effect, van der Waals forces and 
hydrogen bonding and does not change the 
secondary structure of the HSA after 
complexation[34]. In another study, is claimed 
that caffeine, theophylline, and theobromine are 
stabilizing in the complex with HSA by 
hydrophobic interaction according to the 
calculation of free energy changes (∆G), enthalpy 
change (∆H), and entropy change (∆S) at different 
 




temperatures [35]. The interaction of a series of 
acetylcholinesterase inhibitors (AChEIs; 
donepezil, galanthamine, huperzine and 
neostigmine) with human serum albumin (HSA) 
was studied using a biochromatographic 
approach. A comparative thermodynamic study 
with benzodiazepine molecules was also done to 
determine the potential binding site of these drugs 
on HSA. The ∆H◦ and ∆S◦ values for donepezil, 
galanthamine and neostigmine, were negative due 
to van der  Waals interactions and hydrogen 
bonding which govern this association with 
albumin where as the positive values of ∆H◦ and 
∆S◦ of huperzine binding on HSA indicated a 
predominance of hydrophobic interactions [36]. A 
highly  lipophilic neutral tricyclic compound, 
Carbamazepine (CBZ), can also change the 
secondary structure of the HSA following 
interaction with the protein under the simulative  
physiological conditions confirmed by circular 
dichroism and FT-IR spectroscopy [37]. 
7) Chinese medicine 
    The interaction of sinomenine with human 
serum albumin (HSA) in the absence and 
presence  of urea has been studied by 
fluorescence. Sinomenine is one of alkaloids 
extracted from Chinese medical plant, [11–13]. 
The results revealed a static quenching 
mechanism play a role in the complexes.  
However, the binding ability of sinomenine to 
denatured HSA is weaker than that of sinomenine 
to native HSA. Urea causes HSA-sinomenine 
complex become more stable compared to the free 
HSA [38]. The interaction of Salvianolic acid B 
(Sal B) with human serum albumin (HSA) was 
investigated by fluorescence and circular 
dichroism (CD). Salvia miltiorrhiza (Danshen) is 
a popular traditional Chinese herb widely used in 
treatment of coronary heart disease [14]. The CD 
spectroscopy indicated that the secondary 
structure of HSA is not changed in the presence of 
Sal B. Furthermore, the effect of metal ions on Sal 
B-HSA complex was also studied [39]. The 
interaction between Daphnin with human serum 
albumin has been studied by spectroscopic 
methods such as: Fourier transform infrared (FT-
IR). Daphnin (Chinese name: ruixiang) is a folk 
medicine in China that is used for reliefing of 





) and the molecular modeling study indicated 
that hydrophobic forces play an important role to 
stabilize the Daphnin–HSA complex [40]. In 
addition, the effects of other Chinese medicines 
such as: icariin [41], Puerarin[42], honokiol [43], 
three iridoid glycosides extracted from Cornus 
officinalis Sieb (ET Zucc). (CIG) [44], flavonol 
drugs, kaempferol , galangin [45] and 
tetramethylpyrazine (TMPZ) [46] on human 
serum albumin (HSA) were studied.  
8) Pain killer 
    The interaction between ibuprofen whit human 
serum albumin (HSA) has been studied by Small 
angle X-ray scattering (SAXS) technique. The 
work represents a type of analysis which could be 
exploited in future investigations on proteins in 
solution, in the binding of drugs or endogenous 
compounds and in the pharmacokinetic properties 
as well as in the study of allosteric effects, 
cooperation or anti cooperation mechanisms[47].  
9) Anti-insect 
    The interaction of amodiaquine (AQ) (drug for 
Malaria) with human serum albumin (HSA) has 
been studied by fluorescence spectroscopy. Based 
on the sign and magnitude of the enthalpy and 
entropy changes, hydrogen bond and van der 
Waals forces were  suggested as the main 
interacting forces .The binding of AQ to HSA was 
modeled by  molecular docking and molecular 
dynamic simulation methods. Az a result AQ 
binds mainly to the sub-domain IIA of HSA [48]. 
10) Others  
    Sulfonylureas are drugs commonly used to treat 
type II diabetes .The interaction between 
sulfonylurea drugs and the human serum albumin 
has been studied by performance affinity 
chromatography for studying the changes induced 
after the binding [49].Colchicines as a drug used 
for treatment of GOUT, binds to human serum 
albumin and was studied by resonance light 
scattering analysis (RLS) and FT-IR [50].  
 
DISCUSSION 
    In the present work, the binding of varieties of 
drugs to HSA is studied by employing some 
different optical techniques and molecular 
modeling. Not all drugs cause changes in the 
secondary structure of HSA, since some results 
showed no alteration or at least no major changes 
in the secondary structure of HSA after binding to 
special drugs [20, 34, 39].However this stability 
 




in secondary structure is not related to how 
hydrophobic effects, van der  wals forces and 
hydrogen- bonds are modified[20,34,39].On the 
other hand, forces and interactions between drugs 
and HSA can increase the steadiness of drugs-







>0 at different 
temperatures, it is indicated that hydrogen binding 
interactions and van der wals forces played a 
major role during the interactions among most of 
the studied drugs and Albumin [13, 19, 24, 48]. 
Whereas in some cases just hydrophobic bonds 
[4, 7, 14, 15, 35, 40] or only just electrostatic 
interactions [26]. But in most cases, protein-drug 
complex, are stabilizing by collections of different 
forces and bonds [20, 34, 36]. 
In addition binding of different drugs to the 
hydrophobic cavity of sub domain ║A, which is a 
suitable binding site for many drugs [4, 34, 32, 
48], dose not cause the same switches in HSA 
after binding to different drugs for example 
Nobiletin (anti-tumor) and Clozapine (never 
agent) both are set up on sub domain ║A, but one 
of them induce major conformational changer at 
secondary structure whereas another do just little 
alter in this structure [4, 34]. 
Although in low drug concentrations, no major 
conformational changes occur in protein structure, 
a significant increase in protein α-helix and a 
significant decrease in β-sheet structures was 
observed at high drugs contents. This is indicative 
of a partial stabilization of protein secondary 
structure at high drugs concentrations. Whereas 
with increasing other drugs concentration, a 
decrease in protein α-helical content and an 
increase in amounts of β-sheets and random coil  
structures can be observed[24,25]. Thus drugs 
concentration is not main factor for suggesting 
how they have impact on secondary structure. 
 The reports indicated that the probable 
mechanism of some drug's interaction with HSA 
is a static quenching process. The binding 
process was exothermic, enthalpy driven and 
spontaneous, as indicated by the thermodynamic 
parameters analyzed, and the major part of the 
action force is van der wals, H-bonds and 
hydrophobic interactions [27]. It seems that if 
drugs are attached to the hydrophobic amino 
acids, they would affect the molecular quenching 
[14, 27] even so they bind to the others site 
where have no quenching effects [28]. Moreover 











) increases quenching impacts [7, 39], 
decreases the binding constant of the drug –HSA 
complex and increases the free concentration of 
unbound drugs, this declines the storage time of 
the drugs in blood plasma as well as an 
enhancement of the maximum effectiveness of 
the drugs, and these effects are significant in 
vivo. Studying properties of the drugs binding to 
physiologically important protein HSA is greatly 
important in pharmacy, pharmacology and   
biochemistry, which may provide some 
references for the rational use of drugs in the 
clinic [39].  
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